Epidemiology and Clinical Outcomes of Non-HACEK Gram-Negative Infective Endocarditis

Abstract Background The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death. Methods Adult patients with GNIE were included if they met modified Duke criteria for defini...

Full description

Saved in:
Bibliographic Details
Published inOpen forum infectious diseases Vol. 10; no. 3; p. ofad052
Main Authors Shah, Sunish, Clarke, Lloyd G, Shields, Ryan K
Format Journal Article
LanguageEnglish
Published US Oxford University Press 01.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death. Methods Adult patients with GNIE were included if they met modified Duke criteria for definitive infective endocarditis (IE) between April 2010 and December 2021. Patients were identified using Boolean search terms. Clinical failure was a defined as a composite of all-cause 42-day mortality or microbiologic failure. All analyses were performed using Stata, version 15.1. Results One-hundred twenty-three patients were included. The most common pathogens were Serratia spp. (43%), Pseudomonas aeruginosa (21%), and Klebsiella spp. (14%). Fifty-two percent of cases were among persons who injection drugs (PWID; n = 64), for whom Serratia spp. (70%) was the most common cause of GNIE. Overall, patients infected with P. aeruginosa had higher microbiologic failure rates than other patients (23% vs 6%; P = .004). Patients who received combination therapy (n = 53) had comparable median lengths of stay (23 vs 19.5 days; P = .412), microbiologic failure rates (11.3% vs 7.1%; P = .528), clinical failure rates (18.9% vs 22.9%; P = .592), and 90-day mortality rates (13.2% vs 25.7%; P = .088) as those treated with monotherapy. After applying stepwise logistic regression, male gender, Pitt Bacteremia Score, and not receiving surgical intervention despite a surgical indication were associated with clinical failure. Conclusions This is the first study to identify Serratia spp. as the most common etiology of GNIE, which was particularly true among PWID. Microbiologic failures occurred most commonly among P. aeruginosa, and use of combination antimicrobial therapy did not improve clinical outcomes.
AbstractList Abstract Background The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death. Methods Adult patients with GNIE were included if they met modified Duke criteria for definitive infective endocarditis (IE) between April 2010 and December 2021. Patients were identified using Boolean search terms. Clinical failure was a defined as a composite of all-cause 42-day mortality or microbiologic failure. All analyses were performed using Stata, version 15.1. Results One-hundred twenty-three patients were included. The most common pathogens were Serratia spp. (43%), Pseudomonas aeruginosa (21%), and Klebsiella spp. (14%). Fifty-two percent of cases were among persons who injection drugs (PWID; n = 64), for whom Serratia spp. (70%) was the most common cause of GNIE. Overall, patients infected with P. aeruginosa had higher microbiologic failure rates than other patients (23% vs 6%; P = .004). Patients who received combination therapy (n = 53) had comparable median lengths of stay (23 vs 19.5 days; P = .412), microbiologic failure rates (11.3% vs 7.1%; P = .528), clinical failure rates (18.9% vs 22.9%; P = .592), and 90-day mortality rates (13.2% vs 25.7%; P = .088) as those treated with monotherapy. After applying stepwise logistic regression, male gender, Pitt Bacteremia Score, and not receiving surgical intervention despite a surgical indication were associated with clinical failure. Conclusions This is the first study to identify Serratia spp. as the most common etiology of GNIE, which was particularly true among PWID. Microbiologic failures occurred most commonly among P. aeruginosa, and use of combination antimicrobial therapy did not improve clinical outcomes.
BackgroundThe objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death. MethodsAdult patients with GNIE were included if they met modified Duke criteria for definitive infective endocarditis (IE) between April 2010 and December 2021. Patients were identified using Boolean search terms. Clinical failure was a defined as a composite of all-cause 42-day mortality or microbiologic failure. All analyses were performed using Stata, version 15.1. ResultsOne-hundred twenty-three patients were included. The most common pathogens were Serratia spp. (43%), Pseudomonas aeruginosa (21%), and Klebsiella spp. (14%). Fifty-two percent of cases were among persons who injection drugs (PWID; n = 64), for whom Serratia spp. (70%) was the most common cause of GNIE. Overall, patients infected with P. aeruginosa had higher microbiologic failure rates than other patients (23% vs 6%; P = .004). Patients who received combination therapy (n = 53) had comparable median lengths of stay (23 vs 19.5 days; P = .412), microbiologic failure rates (11.3% vs 7.1%; P = .528), clinical failure rates (18.9% vs 22.9%; P = .592), and 90-day mortality rates (13.2% vs 25.7%; P = .088) as those treated with monotherapy. After applying stepwise logistic regression, male gender, Pitt Bacteremia Score, and not receiving surgical intervention despite a surgical indication were associated with clinical failure. ConclusionsThis is the first study to identify Serratia spp. as the most common etiology of GNIE, which was particularly true among PWID. Microbiologic failures occurred most commonly among P. aeruginosa, and use of combination antimicrobial therapy did not improve clinical outcomes.
The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death. Adult patients with GNIE were included if they met modified Duke criteria for definitive infective endocarditis (IE) between April 2010 and December 2021. Patients were identified using Boolean search terms. Clinical failure was a defined as a composite of all-cause 42-day mortality or microbiologic failure. All analyses were performed using Stata, version 15.1. One-hundred twenty-three patients were included. The most common pathogens were spp. (43%), (21%), and spp. (14%). Fifty-two percent of cases were among persons who injection drugs (PWID; n = 64), for whom spp. (70%) was the most common cause of GNIE. Overall, patients infected with had higher microbiologic failure rates than other patients (23% vs 6%; = .004). Patients who received combination therapy (n = 53) had comparable median lengths of stay (23 vs 19.5 days; = .412), microbiologic failure rates (11.3% vs 7.1%; = .528), clinical failure rates (18.9% vs 22.9%; = .592), and 90-day mortality rates (13.2% vs 25.7%; = .088) as those treated with monotherapy. After applying stepwise logistic regression, male gender, Pitt Bacteremia Score, and not receiving surgical intervention despite a surgical indication were associated with clinical failure. This is the first study to identify spp. as the most common etiology of GNIE, which was particularly true among PWID. Microbiologic failures occurred most commonly among , and use of combination antimicrobial therapy did not improve clinical outcomes.
Author Clarke, Lloyd G
Shah, Sunish
Shields, Ryan K
Author_xml – sequence: 1
  givenname: Sunish
  orcidid: 0000-0002-8873-1451
  surname: Shah
  fullname: Shah, Sunish
  email: sunishshah93@gmail.com
– sequence: 2
  givenname: Lloyd G
  surname: Clarke
  fullname: Clarke, Lloyd G
– sequence: 3
  givenname: Ryan K
  orcidid: 0000-0001-9794-5665
  surname: Shields
  fullname: Shields, Ryan K
  email: shieldsrk@upmc.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36968963$$D View this record in MEDLINE/PubMed
BookMark eNp9kbtPwzAQxi0E4r0xo2wwELDjuI4nhKJSEFVZYLYufhSjxA5xgsR_T6ClgoXlHrqfvjvdd4C2ffAGoROCLwkW9CpYp8cAGrNsC-1nNCvSQjC-_aveQ8cxvmKMCcEMc7GL9uhETAoxofvoado6bRoX6rD8SMDrpKyddwrq5HHoVWhMTIJNFsGndzfl9CGZddCkC7OE3r2b5N5bo76rqddBQadd7-IR2rFQR3O8zofo-Xb6VN6l88fZfXkzT1Ve5H1qCaPYWFIpoQqutGWUZMyOLWYaBAeSU2Yxq0RmqkJlhuc5UFACRAG8EvQQXa9026FqjFbG9x3Usu1cA92HDODk34l3L3IZ3iXBmOZMZKPC-VqhC2-Dib1sXFSmrsGbMESZcUE4ZpzREb1YoaoLMXbGbvYQLL_MkF9myLUZI376-7YN_PP6EThbAWFo_5f6BGA7lvE
CitedBy_id crossref_primary_10_1093_jac_dkae205
crossref_primary_10_3390_tropicalmed8050283
crossref_primary_10_1093_jac_dkad254
crossref_primary_10_1007_s15010_024_02311_z
crossref_primary_10_24969_hvt_2024_460
Cites_doi 10.1097/IPC.0000000000000834
10.7326/0003-4819-147-12-200712180-00002
10.1161/CIR.0000000000000296
10.1007/s00392-020-01686-x
10.4081/monaldi.2020.1359
10.1128/AAC.02208-17
10.1097/MD.0b013e3181b8bedc
10.1371/journal.pone.0230199
10.1128/AAC.00925-21
10.1093/ofid/ofab102
10.1086/313753
10.1016/j.ejim.2021.04.021
10.1093/eurheartj/ehv319
10.1001/archinte.1980.00330140057018
10.7326/0003-4819-84-1-29
10.1097/IPC.0000000000000614
10.1111/j.1469-0691.2011.03570.x
ContentType Journal Article
Copyright The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2023
The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Copyright_xml – notice: The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2023
– notice: The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
DBID TOX
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1093/ofid/ofad052
DatabaseName Oxford Open (Open Access)
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2328-8957
EndPage ofad052
ExternalDocumentID 10_1093_ofid_ofad052
36968963
10.1093/ofid/ofad052
Genre Journal Article
GroupedDBID 0R~
53G
5VS
AAFWJ
AAMVS
AAPPN
AAPXW
AAVAP
ABDBF
ABPTD
ABXVV
ACGFS
ADBBV
ADHZD
ADPDF
ADRAZ
AENZO
AFPKN
AFULF
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AOIJS
BAWUL
BAYMD
BCNDV
BTTYL
CIDKT
DIK
EBS
EJD
GROUPED_DOAJ
H13
HYE
IAO
KQ8
KSI
M48
M~E
O9-
OAWHX
OJQWA
OK1
OVD
OVEED
PEELM
ROL
ROX
RPM
TEORI
TJX
TOX
ITC
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c484t-f1530ef1bc9c87cdf53125fbc905da97a1435f05b92eb8c2e744a3ac9a98a7b93
IEDL.DBID RPM
ISSN 2328-8957
IngestDate Tue Sep 17 21:31:48 EDT 2024
Sat Oct 05 05:47:36 EDT 2024
Thu Sep 26 18:20:45 EDT 2024
Sat Sep 28 08:17:24 EDT 2024
Wed Aug 28 03:17:33 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords IVDA
endocarditis
gram-negative
PWID
Serratia
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c484t-f1530ef1bc9c87cdf53125fbc905da97a1435f05b92eb8c2e744a3ac9a98a7b93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Potential conflicts of interest. No funding sources were received for this study. R.K.S. has served as a consultant for Allergan, Cidara, Shionogi, Menarini, Melinta, Merck, Entasis, Utility, and Venatorx and has received investigator-initiated funding from Merck, Melinta, Shionogi, and Venatorx. All other authors report no potential conflicts.
ORCID 0000-0001-9794-5665
0000-0002-8873-1451
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034592/
PMID 36968963
PQID 2791705753
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10034592
proquest_miscellaneous_2791705753
crossref_primary_10_1093_ofid_ofad052
pubmed_primary_36968963
oup_primary_10_1093_ofid_ofad052
PublicationCentury 2000
PublicationDate 2023-03-01
PublicationDateYYYYMMDD 2023-03-01
PublicationDate_xml – month: 03
  year: 2023
  text: 2023-03-01
  day: 01
PublicationDecade 2020
PublicationPlace US
PublicationPlace_xml – name: US
– name: United States
PublicationTitle Open forum infectious diseases
PublicationTitleAlternate Open Forum Infect Dis
PublicationYear 2023
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Mills (2023032309161621400_) 1976; 84
Calderón Parra (2023032309161621400_) 2021; 92
El-Dalati (2023032309161621400_) 2020; 28
Kelly (2023032309161621400_) 2021; 65
Veve (2023032309161621400_) 2020; 15
Van Camp (2023032309161621400_) 2020; 109
Thomas (2023032309161621400_) 2020; 90
Morpeth (2023032309161621400_) 2007; 147
Baddour (2023032309161621400_) 2015; 132
Reyes (2023032309161621400_) 2009; 88
Shah (2023032309161621400_) 2021; 8
Cooper (2023032309161621400_) 1980; 140
Substance Abuse and Mental Health Services Administration (2023032309161621400_) 2021
Falcone (2023032309161621400_) 2018; 62
Magiorakos (2023032309161621400_) 2012; 18
Habib (2023032309161621400_) 2015; 36
Li (2023032309161621400_) 2000; 30
Von pycocyaneus-sptikamie mit komplizierender (2023032309161621400_) 1899; 25
Schechter (2023032309161621400_) 2018; 26
References_xml – volume: 28
  start-page: 138
  year: 2020
  ident: 2023032309161621400_
  article-title: The clinical impact of 16S ribosomal RNA polymerase chain reaction bacterial sequencing in infectious endocarditis: a single center experience
  publication-title: Infect Dis Clin Pract
  doi: 10.1097/IPC.0000000000000834
  contributor:
    fullname: El-Dalati
– volume: 25
  start-page: 113
  year: 1899
  ident: 2023032309161621400_
  article-title: Pyocyaneous endocarditis in kindesalter
  publication-title: Centrlabl f Bakt
  contributor:
    fullname: Von pycocyaneus-sptikamie mit komplizierender
– volume: 147
  start-page: 829
  year: 2007
  ident: 2023032309161621400_
  article-title: Non-HACEK gram-negative Bacillus endocarditis
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-147-12-200712180-00002
  contributor:
    fullname: Morpeth
– year: 2021
  ident: 2023032309161621400_
  contributor:
    fullname: Substance Abuse and Mental Health Services Administration
– volume: 132
  start-page: 1435
  year: 2015
  ident: 2023032309161621400_
  article-title: Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000296
  contributor:
    fullname: Baddour
– volume: 109
  start-page: 1573
  year: 2020
  ident: 2023032309161621400_
  article-title: Disturbing effect of lockdown for COVID-19 on the incidence of infective endocarditis: a word of caution
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-020-01686-x
  contributor:
    fullname: Van Camp
– volume: 90
  start-page: 614
  year: 2020
  ident: 2023032309161621400_
  article-title: Gram-negative infective endocarditis: a retrospective analysis of 10 years data on clinical spectrum, risk factor and outcome
  publication-title: Monaldi Arch Chest Dis
  doi: 10.4081/monaldi.2020.1359
  contributor:
    fullname: Thomas
– volume: 62
  start-page: e02208
  year: 2018
  ident: 2023032309161621400_
  article-title: Risk factors and outcomes of endocarditis due to non-HACEK gram-negative bacilli: data from the prospective multicenter Italian endocarditis study cohort
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.02208-17
  contributor:
    fullname: Falcone
– volume: 88
  start-page: 294
  year: 2009
  ident: 2023032309161621400_
  article-title: Resurgence of Pseudomonas endocarditis in Detroit, 2006–2008
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0b013e3181b8bedc
  contributor:
    fullname: Reyes
– volume: 15
  year: 2020
  ident: 2023032309161621400_
  article-title: Epidemiology and outcomes of non-HACEK infective endocarditis in the Southeast United States
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0230199
  contributor:
    fullname: Veve
– volume: 65
  year: 2021
  ident: 2023032309161621400_
  article-title: Incidence and predictors of gram-negative bacilli in hospitalized people who inject drugs with injection drug use-attributable infections
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00925-21
  contributor:
    fullname: Kelly
– volume: 8
  year: 2021
  ident: 2023032309161621400_
  article-title: Ampicillin-ceftriaxone vs ampicillin-gentamicin for definitive therapy of Enterococcus faecalis infective endocarditis: a propensity score-matched, retrospective cohort analysis
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofab102
  contributor:
    fullname: Shah
– volume: 30
  start-page: 633
  year: 2000
  ident: 2023032309161621400_
  article-title: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis
  publication-title: Clin Infect Dis
  doi: 10.1086/313753
  contributor:
    fullname: Li
– volume: 92
  start-page: 71
  year: 2021
  ident: 2023032309161621400_
  article-title: Non-HACEK gram negative bacilli endocarditis: analysis of a national prospective cohort
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2021.04.021
  contributor:
    fullname: Calderón Parra
– volume: 36
  start-page: 3075
  year: 2015
  ident: 2023032309161621400_
  article-title: 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehv319
  contributor:
    fullname: Habib
– volume: 140
  start-page: 199
  year: 1980
  ident: 2023032309161621400_
  article-title: Serratia endocarditis. A follow-up report
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1980.00330140057018
  contributor:
    fullname: Cooper
– volume: 84
  start-page: 29
  year: 1976
  ident: 2023032309161621400_
  article-title: Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-84-1-29
  contributor:
    fullname: Mills
– volume: 26
  start-page: 216
  year: 2018
  ident: 2023032309161621400_
  article-title: Serratia marcescens infectious endocarditis
  publication-title: Infect Dis Clin Pract
  doi: 10.1097/IPC.0000000000000614
  contributor:
    fullname: Schechter
– volume: 18
  start-page: 268
  year: 2012
  ident: 2023032309161621400_
  article-title: Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2011.03570.x
  contributor:
    fullname: Magiorakos
SSID ssj0001105079
Score 2.329947
Snippet Abstract Background The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify...
The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with...
BackgroundThe objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors...
SourceID pubmedcentral
proquest
crossref
pubmed
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage ofad052
SubjectTerms Major
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bS8MwFA5jgvgi3p03IuhjtOtlTR5ExticyubLBnsrSZPoYHa6duD-vSdtNrch7KW0NGnLOSfJl-bk-xC68agAUMFjokMhiF8Na4RRVxNqJFSZBoQUm_3OnW6t3fdfBsGghOZqo9aA6b9TO6Mn1Z-M7n6-Z4_Q4B8sGdI9eEHCgUsngM54yzWUXCaJzwL9_G8LwAgnZDbzfb3Sypi0ss9tCW6uZ00uDUOtPbRr8SOuFw7fRyWVHKDtjl0hP0S95p_k6wzzRGLL_DnCb9MMwkuleKxxd5yQdr3RfMVPE_5Juuo9JwDHz0VuFpw1EwnDHIRPNkyPUL_V7DXaxConkNinfkY09GOO0lURs5iGsdTQ0txAw6UTSM5CblCSdgLBXCVo7KrQ97nHY8YZ5aFg3jEqJ-NEnSLMBFeOlFUKr_epdKCyBlTBBXVqSrphBd3ObRd9FQQZUbGw7UXGxpG1cQVhMOyGItdzq0cQ5GblgidqPE0jCBtD-wNTqwo6KbyweJIRJKTQjVQQXfHPooAh0F69kww_ciLtqmHnCZh7tvnbztGOEZovss8uUDmbTNUlwJFMXOWR9guukeMZ
  priority: 102
  providerName: Scholars Portal
Title Epidemiology and Clinical Outcomes of Non-HACEK Gram-Negative Infective Endocarditis
URI https://www.ncbi.nlm.nih.gov/pubmed/36968963
https://search.proquest.com/docview/2791705753
https://pubmed.ncbi.nlm.nih.gov/PMC10034592
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED5BB8SCeFNeMhKMpmmaNPaIqpYCamEoUrfIT6hEXUTTgX_POQ9oWZBYrESxk-j8xf4uPn8HcNliEkmFUNQmUtKombQpZ6GlzKdQ5RYZkvL7nQfDdv85uh_H4zVoV3th8qB9JSfX7m167SaveWzl-1Q1qjixxtOg0_SqKjEPG-uwjghd8tHzPytIGYKEl1Hu6LE3sJs0FkIHcbgy_6zsaVuilr8jJJemnN42bJVckdwU77QDa8btwsagXA3fg1H3J73rJxFOk1Ll8408LjKEkpmTmSXDmaP9m073gdx-iCkdmpdc7JvcFXFYeNR1Gqc0hEo2me_Dc6876vRpmSWBqohFGbU4ZgXGNqXiiiVKW_yqwtjiaRBrwRPhGZENYslDI5kKTRJFoiUUF5yJRPLWAdTczJkjIFwKE2jdZPj4iOkAG1tkEEKyoG10mNThqrJd-l6IYaTFInYr9TZOSxvXgaBh_6hyUVk9RUD7VQrhzGwxTxEiXuIH3ag6HBa98H0nn3yQ4ZBRB7bSP98VvFj26hXEUC6aXWHm-P9NT2DTJ5svItBOoZZ9LMwZUpJMnueuPJaDiJ3naMRy9Dj-As9d6Ls
link.rule.ids 230,315,730,783,787,867,888,1607,2228,24332,27938,27939,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JTxsxGP3EIpVeCi1L01JwJTg6mUxmMvYRRaFhSdpDENxGXtuIxEFkcii_ns-zQMIFwWU0I9uz6Hl5Hj-_D-CoxSSSCqGoTaSkUTNpU85CS5kPocotMiTl9zv3B-3eVXR-E9-sQLvaC5OL9pUc1d14Unejf7m28m6iGpVOrPGn32l6V5WYh41VWMcGG7QXZun5vxUkDUHCS507ztkbCJTGg9BBHC6NQEu72hbI5UuN5MKgc7oJ19XrFlqT2_o8k3X18MLJ8e3fswWfSh5KTor0z7Bi3Bf40C9X2rdh2H0OHfufCKdJ6SA6Jr_nGVZTMyNTSwZTR3snne4F-XUvJnRg_uZG4uSs0HjhWddpHC6xGmaj2Q5cnXaHnR4tIzBQFbEooxb7w8DYplRcsURpiy02jC1eBrEWPBGebdkgljw0kqnQJFEkWkJxwZlIJG_twpqbOvMVCJfCBFo3GT4-YjrAwhbZiZAIn9FhUoPjCpX0rjDaSIsF8lbq0UtL9GpAELJXsvys8EyxsfgVEOHMdD5Lsfp5-yCcotVgr8D36U4-sCHD7qgGbAn5pwzeiHs5BfHMDbkr_L69v-ghbPSG_cv08mxw8R0--qD2hdJtH9ay-7n5gdQnkwd5PX8EYPUIAA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT9swGP3EQEJ7GWMX1l3Ak7ZHN26aNPYj6lrKWDseQELaQ-QrVKNuRdMH9uv3ORfW8jKJlyhR7Fx0PsfH8fH5AL50uUJSITV1mVI06WQ9KnjsKA8pVIVDhqTDeufxpDe6TL5fpVe1qnJZyyq9VtO2v521_fSm1FYuZjpqdGLR-bjfCa4qqYijhXHRM9jBRsv42ki9_L-CxIFlota647g9QrAMbqRhabzRC22sbFsjmI91kmsdz3APfjWPXOlNfrdXhWrrP4_cHJ_2Ti_hRc1HyXFVZh-2rH8Fu-N6xv01XAz-pZC9J9IbUjuJ3pKfqwLD1S7J3JHJ3NPRcX9wRk7u5IxO7HVpKE5OK60X7g28wW4Tw7GYLt_A5XBw0R_ROhMD1QlPCurwu8is6ygtNM-0cdhy49ThIUuNFJkMrMuxVInYKq5jmyWJ7EotpOAyU6L7Frb93Nt3QISSlhnT4Xj7hBuGlR2yFKk461kTZy342iCTLyrDjbyaKO_mAcG8RrAFBGH7T5HPDaY5NpowEyK9na-WOYZhsBHCoVoLDiqMH64UEhxy_Cy1gG-g_1AgGHJvnkFMS2PuBsP3T696BLvn34b5j9PJ2Qd4HnLbV4K3j7Bd3K3sJ2RAhTosQ_0vkhsKgA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+and+Clinical+Outcomes+of+Non-HACEK+Gram-Negative+Infective+Endocarditis&rft.jtitle=Open+forum+infectious+diseases&rft.au=Shah%2C+Sunish&rft.au=Clarke%2C+Lloyd+G&rft.au=Shields%2C+Ryan+K&rft.date=2023-03-01&rft.pub=Oxford+University+Press&rft.eissn=2328-8957&rft.volume=10&rft.issue=3&rft_id=info:doi/10.1093%2Fofid%2Fofad052&rft.externalDocID=10.1093%2Fofid%2Fofad052
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2328-8957&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2328-8957&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2328-8957&client=summon